Production of insulin by recombinant DNA techniques was achieved by an American company, Eli Lilly, in 1983. They prepared two DNA sequences corresponding to A and B-chains of the human insulin and introduction them into the plasmids of E. coli for production. The A and B chains produced were separated, extracted and combined by creating disulphide bonds to form human insulin